Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

JNJ Regrets Paying For Controversial Prison Testing With Asbestos: Bloomberg

According to a Bloomberg News report, unsealed court documents show that Johnson & Johnson (NYSE:JNJ) paid for a study that injected ten incarcerated Black men with asbestos as part of the Company's early talcum powder trials.

In one study, inmates were paid to be injected with potentially cancer-causing asbestos so JNJ could compare its effect on their skin versus that of talc, a key component in its baby powder.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.